There Could Be An Aids Vaccine in Four Years,' Says Nobel Prize winner


 
927
Shares
 

 

A French scientist awarded the Nobel Prize for discovering the Aids virus has  predicted there would be a 'therapeutic vaccine' for the disease within four years.

Luc Montagnier and his team discovered HIV at the French Pasteur Institute in Paris 25 years ago, and have been awarded the prestigious prize along with other scientists who worked on discovering the root of the virus.

Montagnier, 76, said a treatment could be possible in the future with a 'therapeutic' rather than preventive vaccine for which results might be published in three or four years if financial backing is forthcoming.

'I think it will be possible with a therapeutic vaccine rather than preventative vaccinations. We would give it to people who are already infected.

A therapeutic vaccine prevents disease from flourishing after it has taken hold.

The Nobel Assembly of Sweden's Karolinska Institute praised their work, saying: 'The discovery was one prerequisite for the current understanding of the biology of the disease and its antiretroviral treatment.'

The other half of the Nobel prize was awarded for the German scientist's research that 'went against current dogma' by setting forth that oncogenic human papilloma virus (HPV) caused cervical cancer, the second most common cancer among women.

'His discovery has led to characterization of the natural history of HPV infection, an understanding of mechanisms of HPV-induced carcinogenesis and the development of prophylactic vaccines against HPV acquisition,' the Assembly said.

Medicine is traditionally the first of the Nobel prizes awarded each year.

The prizes for achievement in science, literature and peace were first awarded in 1901 in accordance with the will of dynamite inventor and businessman Alfred Nobel.

 

Copyright 2008- American Society of Registered Nurses (ASRN.ORG)-All Rights Reserved



 
927
Shares
 

Articles in this issue:

Masthead

  • Masthead

    Editor-in Chief:
    Kirsten Nicole

    Editorial Staff:
    Kirsten Nicole
    Stan Kenyon
    Robyn Bowman
    Kimberly McNabb
    Lisa Gordon
    Stephanie Robinson

    Contributors:
    Kirsten Nicole
    Stan Kenyon
    Liz Di Bernardo
    Cris Lobato
    Elisa Howard
    Susan Cramer

Leave a Comment

Please keep in mind that all comments are moderated. Please do not use a spam keyword or a domain as your name, or else it will be deleted. Let's have a personal and meaningful conversation instead. Thanks for your comments!

Image Captcha